fluoxetine has been researched along with mianserin in 110 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (10.00) | 18.7374 |
1990's | 28 (25.45) | 18.2507 |
2000's | 37 (33.64) | 29.6817 |
2010's | 31 (28.18) | 24.3611 |
2020's | 3 (2.73) | 2.80 |
Authors | Studies |
---|---|
Costanzo, MJ; Gardocki, JF; Maryanoff, BE; McComsey, DF; Nortey, SO; Schneider, CR; Setler, PE; Shank, RP | 1 |
Hamblin, MW; Monsma, FJ; Shen, Y; Sibley, DR; Ward, RP | 1 |
Topliss, JG; Yoshida, F | 1 |
Buck, LB; Petrascheck, M; Ye, X | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Gryboś, A; Grzeszczuk, D; Głuch-Lutwin, M; Leśniak, A; Ostrowska, K; Sacharczuk, M; Siwek, A; Trzaskowski, B | 1 |
Dean, A; Jick, H; Ulcickas, M | 1 |
Costa, D | 1 |
Nakamura, S | 1 |
Kapur, S; Mann, JJ | 1 |
Baldwin, D; Bullock, T; Montgomery, D; Montgomery, S | 1 |
Kleven, MS; Sparber, SB | 1 |
DeNoble, VJ; Spencer, KR; Strek, KF | 1 |
Asakura, M; Imafuku, J; Kubota, H; Nakanishi, J; Nishizaki, J; Osada, K; Sato, A; Shibata, M; Shimbo, K; Tsukamoto, T | 1 |
Gillespie, DD; Manier, DH; Sulser, F | 1 |
Asakura, M; Hasegawa, K; Imafuku, J; Ino, M; Kubota, H; Nishizaki, J; Sato, A; Shinbo, K; Tsukamoto, T | 1 |
Smith, DF | 1 |
Christie, M; Mehmet, A; Muijen, M; Roy, D; Silverstone, T | 1 |
Chuang, DM; Costa, E; Nakaki, T; Roth, BL | 1 |
Broekkamp, CL; Garrigou, D; LLoyd, KG | 1 |
Sugrue, MF | 1 |
Kreiss, DS; Lucki, I | 1 |
Hrdina, PD; Vu, TB | 1 |
Dziedzicka-Wasylewska, M; Maj, J; Rogoz, R; Rogóz, Z; Skuza, G | 1 |
Backer, MM; Pick, CG; Schreiber, S | 1 |
Beauchamp, G; Elie, R; Lavoie, PA | 1 |
Berendsen, HH; Broekkamp, CL | 1 |
Poyurovsky, M; Schneidman, M; Weizman, A | 1 |
Pinder, RM | 1 |
Rowe, PM | 1 |
Bech, P; Dam, J; Lauge, N; Lauritsen, B; Ryde, L; Svejsø, J | 1 |
Kremer, CM; Timmerman, L; van Moffaert, M; Wheatley, DP | 1 |
Benazzi, F | 1 |
Goudemand, M; Rousseaux, M; Thomas, P | 1 |
Campens, D; Libbrecht, I; Maes, M; Meltzer, HY; van Hunsel, F | 1 |
Farah, A | 1 |
Montgomery, SA | 1 |
Bech, P; Breum, L; Hammer, M; Jarløv, N; Raabaek Olsen, L; Schütze, T | 1 |
Thompson, C | 1 |
Nutt, DJ | 1 |
Thase, ME | 1 |
Brown, MC; Guest, JF; Nimmerrichter, AA | 1 |
Andreev, BV; Kudriashova, MF | 1 |
Häggström, L; Nordling, S; Norinder, A | 1 |
Borghi, J; Guest, JF | 1 |
Cryan, JF; Lucki, I | 1 |
Berlin, I; Ferreri, M; Lavergne, F; Payan, C; Puech, AJ | 1 |
Gorman, JM; Nierenberg, AA; Stahl, SM | 1 |
Kremer, C; Quitkin, FM; Taylor, BP | 1 |
Nierenberg, AA | 1 |
Barreau, S; Belzung, C; Calatayud, F; Le Guisquet, AM | 1 |
Busnello, EA; Busnello, JV; Kapczinski, F; Kauer-Sant'Anna, M; Madruga, M; Quevedo, J; Ribeiro, L | 1 |
Ng, B | 1 |
Bouvard, M; Rénéric, JP; Stinus, L | 2 |
Biggio, G; Dazzi, L; Pisul, MG; Purdy, RH; Serra, M | 1 |
Baumann, P; Eap, CB; Zullino, DF | 1 |
Lima, L; Urbina, M | 1 |
Chen, CC; Hong, CJ; Hsiao, CC; Hu, WH; Ruwe, FJ; Tsai, SJ | 1 |
Cormier, JL; DeMartinis, NA; Gary, EM; Gary, KA; McNally, DP; Winokur, A | 1 |
Drobizhev, MIu; Kozyrev, VN; Kraeva, GK; Kubrakov, MA; Smulevich, AB | 1 |
Bateman, DN; Chick, J; Good, AM; Kelly, CA; Masterton, G | 1 |
Norman, TR; Olver, JS | 1 |
Lawrence, RW | 1 |
Moreno, R; Ramakers-van Moorsel, CJ; Schutte, AJ; Versiani, M | 1 |
Aghayan, S; Akhondzadeh, S; Amini, H; Jalili, SA; Pakravan-Nejad, M; Yahyazadeh, O | 1 |
Cela, R; Garcia-Jares, C; Lamas, JP; Llompart, M; Salgado-Petinal, C | 1 |
Lambert, WE; Maudens, KE; Van Peteghem, CH; Wille, SM | 1 |
Albertazzi, P | 1 |
Koht, J; Refsum, H; Solberg, DK | 1 |
Fountoulakis, KN; Iacovides, A; Kaprinis, GS; Koumaris, V; Siamouli, M | 1 |
Arana-Lechuga, Y; Prospero-Garcia, KA; Ramirez-Bermudez, J; Teran-Perez, G; Torres-Ruiz, A; Velazquez-Moctezuma, J | 1 |
Connor, K; Davidson, JR; Vaishnavi, S | 1 |
Olivier, B; Schweitzer, DH; Waldinger, MD; Zwinderman, AH | 1 |
Liang, KY; Liao, SC; Liu, CC | 1 |
Jia, L; Li, YY; Shang, YY | 1 |
Bergeron, R; Blier, P; Hébert, C; Laberge, L; Tremblay, P; Ward, HE | 1 |
Rush, AJ | 1 |
Beauclair, L; Desmarais, JE; Margolese, HC; Wolf, Y | 1 |
Nierenberg, AA; Schutte, AJ; Simmons, JH; Thase, ME; van Oers, HJ; Vrijland, P | 1 |
Agius, M; Gardner, J; Liu, K; Zaman, R | 1 |
Fonseca, C; Laino, CH; Reinés, A; Slobodianik, N; Sterin-Speziale, N | 1 |
Fisar, Z; Hroudová, J; Raboch, J | 1 |
Iwamura, T; Kasai, M; Kato, S; Nisijima, K; Shioda, K; Yoshino, T | 1 |
Cabral, A; Ferreira, LS; Izídio, GS; Macedo, PT; Melo, TG; Ribeiro, AM; Silva, RH; Sousa, DS | 1 |
Johansen, SS; Nielsen, MK | 1 |
Fan, DS; Guo, L; Ji, CX; Li, W; Liang, ZL; Xu, RM; Zhang, JJ | 1 |
Arterburn, D; Bogart, A; Boudreau, DM; Haneuse, S; Simon, G; Theis, MK; Westbrook, E | 1 |
Gądek-Michalska, A; Kabziński, M; Rachwalska, P; Rogóż, Z; Sadaj, W | 1 |
Clarke, G; Cryan, JF; Dinan, TG; Griffin, BT; O'Brien, FE | 1 |
Arteta, B; Basta-Kaim, A; Budziszewska, B; Curzytek, K; Duda, W; Grygier, B; Kubera, M; Lasoń, W; Leśkiewicz, M; Maes, M | 1 |
Purslow, C | 1 |
Abe, M; Mori, Y; Nakata, S; Ochi, S; Ueno, S; Yamazaki, K; Yoshino, Y | 1 |
Andersson, SI; Broaddus, CD; Gomez-Amaro, RL; Kardakaris, R; Niculescu, AB; Petrascheck, M; Rangaraju, S; Solis, GM | 1 |
García-Fuster, MJ; García-Sevilla, JA | 1 |
Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X | 1 |
Kamińska, K; Pańczyszyn-Trzewik, P; Rogóż, Z; Sowa-Kućma, M | 1 |
Hu, L; Lei, P; Liu, S; Pan, C; Qu, H; Shen, Y; Wu, M; Yang, M | 1 |
Baldwin, DS; Everitt, H; Lipinska, G; Malizia, AL; Manson, CC; Mayers, A; Stuart, B; Wilson, S | 1 |
Carleton, BC; Etminan, M; Guo, MY; Kezouh, A; Kim, DD; Procyshyn, RM; Samii, A | 1 |
Chmielarz, P; Chorązka, K; Kowalska, M; Kuśmierczyk, J; Nalepa, I; Rafa-Zabłocka, K; Satała, G | 1 |
Escuder-Gilabert, L; Martín-Biosca, Y; Medina-Hernández, MJ; Pérez-Baeza, M; Sagrado, S | 1 |
Keidan, L; Pick, CG; Schreiber, S | 1 |
17 review(s) available for fluoxetine and mianserin
Article | Year |
---|---|
The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy.
Topics: Antidepressive Agents; Depressive Disorder; Desipramine; Drug Therapy, Combination; Fluoxetine; Fluvoxamine; Humans; Imipramine; Mianserin; Suicide | 1991 |
5-HT reuptake inhibitors, tricyclic antidepressants and suicidal behaviour.
Topics: Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Humans; Mianserin; Paroxetine; Piperidines; Serotonin Antagonists; Suicide; Suicide Prevention | 1991 |
Successful treatment of fluoxetine-induced dystonia with low-dose mianserin.
Topics: Adult; Aged; Depressive Disorder; Dose-Response Relationship, Drug; Dystonia; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 1997 |
New developments in the treatment of depression.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Placebos; Severity of Illness Index; Treatment Outcome | 1999 |
Mirtazapine versus selective serotonin reuptake inhibitors.
Topics: Antidepressive Agents, Tricyclic; Citalopram; Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1999 |
Care of depressed patients with anxiety symptoms.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Citalopram; Clinical Trials as Topic; Comorbidity; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1999 |
Antidepressant treatment of the depressed patient with insomnia.
Topics: Antidepressive Agents, Tricyclic; Comorbidity; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sleep; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 1999 |
Cost-effectiveness of mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in austria.
Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Austria; Cost-Benefit Analysis; Depressive Disorder; Double-Blind Method; Drug Hypersensitivity; Fluoxetine; Humans; Mianserin; Mirtazapine; Retrospective Studies; Severity of Illness Index | 1999 |
[Treatment of depression and cost efficiency. The cost of a tablet is a poor indicator seen from a socioeconomic perspective].
Topics: Adrenergic alpha-Agonists; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cost of Illness; Cost-Benefit Analysis; Depression; Drug Costs; Fluoxetine; Histamine H1 Antagonists; Humans; Mianserin; Mirtazapine; Models, Economic; Socioeconomic Factors; Sweden | 2000 |
Evidence of early onset of antidepressant effect in randomized controlled trials.
Topics: Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Mianserin; Mirtazapine; Personality Inventory; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Do some antidepressants work faster than others?
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Enantiomers' potential in psychopharmacology--a critical analysis with special emphasis on the antidepressant escitalopram.
Topics: Animals; Antidepressive Agents, Second-Generation; Citalopram; Depression; Fluoxetine; Humans; Mental Disorders; Mianserin; Molecular Structure; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Stereoisomerism; Thioridazine; Trimipramine | 2002 |
New formulations of existing antidepressants: advantages in the management of depression.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chemistry, Pharmaceutical; Cyclohexanols; Delayed-Action Preparations; Depression; Drug Evaluation; Fluoxetine; Humans; Mianserin; Mirtazapine; Molecular Conformation; Venlafaxine Hydrochloride | 2004 |
Noradrenergic and serotonergic modulation to treat vasomotor symptoms.
Topics: Citalopram; Cyclohexanols; Female; Fluoxetine; Hot Flashes; Humans; Menopause; Mianserin; Mirtazapine; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Trazodone; Venlafaxine Hydrochloride | 2006 |
Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Patient Dropouts; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Young Adult | 2010 |
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Evidence-Based Medicine; Fluoxetine; Humans; Imipramine; Mianserin; Mirtazapine; Nortriptyline; Paroxetine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sertraline; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2016 |
Antidepressants for insomnia in adults.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Fluoxetine; Humans; Mianserin; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Trazodone | 2018 |
14 trial(s) available for fluoxetine and mianserin
Article | Year |
---|---|
A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients.
Topics: Adolescent; Adult; Affect; Aged; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Psychological Tests; Psychomotor Performance; Random Allocation | 1988 |
Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Mianserin; Observer Variation; Patient Dropouts; Psychiatric Status Rating Scales | 1998 |
Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Drug Administration Schedule; Female; Fluoxetine; Headache; Health Status; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nausea; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Sleep | 1998 |
Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance.
Topics: Adult; Aged; Analysis of Variance; Depressive Disorder; Fluoxetine; Humans; Mianserin; Middle Aged; Pindolol; Psychiatric Status Rating Scales | 1999 |
Relief of SSRI-induced sexual dysfunction with mirtazapine treatment.
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety Disorders; Drug Therapy, Combination; Female; Fluoxetine; Humans; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sexual Dysfunctions, Psychological; Treatment Outcome | 1999 |
Cost-effectiveness of mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in austria.
Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Austria; Cost-Benefit Analysis; Depressive Disorder; Double-Blind Method; Drug Hypersensitivity; Fluoxetine; Humans; Mianserin; Mirtazapine; Retrospective Studies; Severity of Illness Index | 1999 |
Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Treatment Outcome | 2001 |
Mirtazapine versus fluoxetine in the treatment of panic disorder.
Topics: Adolescent; Adult; Analysis of Variance; Antidepressive Agents, Tricyclic; Double-Blind Method; Female; Fluoxetine; Humans; Male; Mianserin; Mirtazapine; Panic Disorder; Selective Serotonin Reuptake Inhibitors | 2001 |
A double-blind, randomized, group-comparative study of the tolerability and efficacy of 6 weeks' treatment with mirtazapine or fluoxetine in depressed Chinese patients.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Ethnicity; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Taiwan; Treatment Outcome | 2003 |
Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Polysomnography; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 2003 |
Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome | 2005 |
Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial.
Topics: Adolescent; Adult; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Humans; Inpatients; Male; Mianserin; Middle Aged; Mirtazapine; Outpatients; Oxazepam; Treatment Outcome | 2005 |
Fluoxetine-mirtazapine interaction may induce restless legs syndrome: report of 3 cases from a clinical trial.
Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Restless Legs Syndrome; Sleep Initiation and Maintenance Disorders | 2006 |
Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
Topics: Adult; Antidepressive Agents; Bupropion; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Psychometrics; Secondary Prevention; Venlafaxine Hydrochloride | 2010 |
80 other study(ies) available for fluoxetine and mianserin
Article | Year |
---|---|
Pyrroloisoquinoline antidepressants. 2. In-depth exploration of structure-activity relationships.
Topics: Animals; Antidepressive Agents; Blepharoptosis; Brain; Catecholamines; Chemical Phenomena; Chemistry; Dopamine; Isoquinolines; Male; Molecular Conformation; Motor Activity; Norepinephrine; Pyrroles; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Serotonin; Serotonin; Structure-Activity Relationship; Synaptosomes; Tetrabenazine | 1987 |
Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Blotting, Northern; Brain Chemistry; Cell Line; Cloning, Molecular; DNA; GTP-Binding Proteins; Lysergic Acid Diethylamide; Molecular Sequence Data; Polymerase Chain Reaction; Psychotropic Drugs; Rats; Receptors, Serotonin; RNA; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Transfection | 1993 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
An antidepressant that extends lifespan in adult Caenorhabditis elegans.
Topics: Aging; Animals; Antidepressive Agents; Caenorhabditis elegans; Caloric Restriction; Humans; Longevity; Methiothepin; Mianserin; Octopamine; Receptors, Biogenic Amine; Receptors, Serotonin, 5-HT4; Serotonin; Serotonin 5-HT4 Receptor Antagonists; Serotonin Antagonists; Signal Transduction; Starvation | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
5-HT
Topics: Animals; Coumarins; Dose-Response Relationship, Drug; Humans; Locomotion; Male; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Molecular Structure; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Structure-Activity Relationship | 2018 |
Comparison of frequencies of suicidal tendencies among patients receiving fluoxetine, lofepramine, mianserin, or trazodone.
Topics: Adolescent; Adult; Aged; Fluoxetine; Humans; Lofepramine; Mianserin; Middle Aged; Suicide; Suicide, Attempted; Trazodone; United Kingdom | 1992 |
Antidepressants and the treatment of stuttering.
Topics: Antidepressive Agents; Clomipramine; Fluoxetine; Humans; Mianserin; Stuttering | 1992 |
Effects of mianserin and fluoxetine on axonal regeneration of brain catecholamine neurons.
Topics: Adrenergic alpha-Antagonists; Animals; Axons; Cerebral Cortex; Denervation; Fluoxetine; Mianserin; Nerve Regeneration; Neurotransmitter Uptake Inhibitors; Norepinephrine; Oxidopamine; Rats; Serotonin | 1991 |
Modification of quasi-morphine withdrawal with serotonin agonists and antagonists: evidence for a role of serotonin in the expression of opiate withdrawal.
Topics: 1-Methyl-3-isobutylxanthine; 5-Hydroxytryptophan; Animals; Fluoxetine; Male; Methysergide; Mianserin; Morphine; Piperidines; Rats; Serotonin; Serotonin Antagonists; Substance Withdrawal Syndrome | 1989 |
Manipulation of serotonin protects against an hypoxia-induced deficit of a passive avoidance response in rats.
Topics: Animals; Avoidance Learning; Cyproheptadine; Dose-Response Relationship, Drug; Fluoxetine; Hypoxia; Ketanserin; Male; Methysergide; Mianserin; Rats; Rats, Inbred Strains; Serotonin; Zimeldine | 1989 |
Involvement of protein kinase in the regulation of beta-adrenergic receptors by antidepressants.
Topics: 5-Hydroxytryptophan; 5,7-Dihydroxytryptamine; Animals; Antidepressive Agents; Bucladesine; Cerebral Cortex; Desipramine; Fluoxetine; Injections, Intraventricular; Male; Maprotiline; Mianserin; Protein Kinase Inhibitors; Protein Kinases; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Time Factors | 1989 |
Dual aminergic regulation of central beta adrenoceptors. Effect of "atypical" antidepressants and 5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Adrenergic beta-Agonists; Animals; Antidepressive Agents; Binding, Competitive; Desipramine; Dihydroalprenolol; Fluoxetine; Male; Mianserin; Models, Biological; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Regression Analysis; Reserpine; Serotonin; Serotonin Antagonists; Tritium | 1989 |
Role of serotonin in the regulation of beta-adrenoceptors by antidepressants.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Cerebral Cortex; Desipramine; Fenclonine; Fluoxetine; In Vitro Techniques; Male; Maprotiline; Membranes; Mianserin; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Serotonin | 1987 |
The stereoselectivity of serotonin uptake in brain tissue and blood platelets: the topography of the serotonin uptake area.
Topics: Alanine; Amphetamine; Aniline Compounds; Animals; Antidepressive Agents; Blood Platelets; Brain; Fluoxetine; Humans; Male; Methadone; Mianserin; Mirtazapine; Morpholines; Naphthalenes; Nefopam; Nomifensine; Paroxetine; Piperidines; Rabbits; Serotonin; Stereoisomerism; Tranylcypromine; Viloxazine; Zimeldine | 1986 |
5-Hydroxytryptamine uptake and imipramine binding sites in neurotumor NCB-20 cells.
Topics: Animals; Binding Sites; Brain; Clomipramine; Cricetinae; Cricetulus; Desipramine; Fluoxetine; Hybrid Cells; Imipramine; Iprindole; Kinetics; Mianserin; Neuroblastoma; Opipramol; Rats; Serotonin | 1985 |
Serotonin-mimetic and antidepressant drugs on passive avoidance learning by olfactory bulbectomised rats.
Topics: Animals; Antidepressive Agents; Avoidance Learning; Clonidine; Ergolines; Fenfluramine; Fluoxetine; Imipramine; Male; Metergoline; Mianserin; Olfactory Bulb; Quipazine; Rats; Serotonin; Serotonin Antagonists | 1980 |
Effects of acutely and chronically administered antidepressants on the clonidine-induced decrease in rat brain 3-methoxy-4-hydroxyphenylethylene-glycol sulphate content.
Topics: Animals; Antidepressive Agents; Brain; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Clonidine; Desipramine; Fluoxetine; Glycols; Iprindole; Male; Methoxyhydroxyphenylglycol; Mianserin; Rats | 1981 |
Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents; Autoreceptors; Corpus Striatum; Fluoxetine; Hippocampus; Male; Mianserin; Rats; Rats, Sprague-Dawley; Serotonin | 1995 |
Chronic fluoxetine treatment upregulates 5-HT uptake sites and 5-HT2 receptors in rat brain: an autoradiographic study.
Topics: Animals; Autoradiography; Brain Chemistry; Fluoxetine; Image Processing, Computer-Assisted; Ketanserin; Male; Mianserin; Paroxetine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Up-Regulation | 1993 |
Antidepressant drugs given repeatedly change the binding of the dopamine D2 receptor agonist, [3H]N-0437, to dopamine D2 receptors in the rat brain.
Topics: Amitriptyline; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Corpus Striatum; Dopamine Agonists; Fluoxetine; Imipramine; Limbic System; Male; Mianserin; Protein Binding; Rats; Rats, Wistar; Receptors, Dopamine D2; Synaptic Membranes; Tetrahydronaphthalenes; Thiophenes; Up-Regulation | 1996 |
Interactions between different antidepressants and morphine alter gastrointestinal transit in mice.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Gastrointestinal Transit; Male; Mianserin; Mice; Mice, Inbred ICR; Morphine; Naloxone; Narcotic Antagonists; Rats | 1997 |
Atypical antidepressants inhibit depolarization-induced calcium uptake in rat hippocampus synaptosomes.
Topics: Animals; Antidepressive Agents, Second-Generation; Calcium; Calcium Channel Blockers; Dose-Response Relationship, Drug; Fluoxetine; Hippocampus; Iprindole; Male; Mianserin; Rats; Rats, Sprague-Dawley; Synaptosomes | 1997 |
Indirect in vivo 5-HT1A-agonistic effects of the new antidepressant mirtazapine.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Conditioning, Operant; Fluoxetine; Male; Mianserin; Mice; Mice, Inbred ICR; Mirtazapine; Pyrazines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Taste | 1997 |
The pharmacologic rationale for the clinical use of antidepressants.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Psychiatric Status Rating Scales; Receptors, Adrenergic; Receptors, Serotonin; Treatment Outcome | 1997 |
How do antidepressants work?
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents; Brain; Desipramine; Fluoxetine; Humans; Mianserin; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin | 1995 |
Serotonin syndrome with mirtazapine-fluoxetine combination.
Topics: Adrenergic alpha-Antagonists; Aged; Antidepressive Agents, Tricyclic; Depression; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome | 1998 |
[Mirtazapin--fast and strong effects].
Topics: Antidepressive Agents, Tricyclic; Depression; Fluoxetine; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors | 1998 |
Divided attention in major depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Attention; Decision Making; Depressive Disorder, Major; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mianserin; Middle Aged; Reaction Time | 1998 |
A case of sequential anti-stress medication in a patient with major depression resistant to amine-reuptake inhibitors.
Topics: Amines; Antidepressive Agents; Anxiety Disorders; Dehydroepiandrosterone; Depressive Disorder, Major; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; GABA Modulators; Humans; Hydrocortisone; Ketoconazole; Lithium Carbonate; Mianserin; Middle Aged; Oxazepam; Prognosis; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Severity of Illness Index; Stress, Psychological | 1999 |
[Neuropharmacological analysis of participation of the serotoninergic system in hyperalgesia in neurotized rats].
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Buspirone; Fluoxetine; Hyperalgesia; Male; Mianserin; Neurotic Disorders; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists | 2000 |
Economic impact of using mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in the UK.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents, Tricyclic; Cost-Benefit Analysis; Depression; Fluoxetine; Humans; Mianserin; Middle Aged; Mirtazapine; Severity of Illness Index; United Kingdom | 2000 |
Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors.
Topics: Animals; Antidepressive Agents; Dose-Response Relationship, Drug; Ethylamines; Fluoxetine; Indoles; Male; Mianserin; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin Receptor Agonists; Swimming | 2000 |
Does mirtazapine have a more rapid onset than SSRIs?
Topics: Antidepressive Agents, Tricyclic; Citalopram; Cross-Sectional Studies; Data Interpretation, Statistical; Depressive Disorder; Double-Blind Method; Fluoxetine; Humans; Mianserin; Mirtazapine; Paroxetine; Patient Dropouts; Placebo Effect; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Research Design; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2001 |
An investigation of the mechanisms responsible for acute fluoxetine-induced anxiogenic-like effects in mice.
Topics: Animals; Anxiety; Arousal; Buspirone; Diazepam; Exploratory Behavior; Fluoxetine; Humans; Male; Mianserin; Mice; Mice, Inbred BALB C; Motor Activity; Quinolines; Receptors, Dopamine; Receptors, Neurotransmitter; Social Environment | 2001 |
Mania associated with mirtazapine augmentation of fluoxetine.
Topics: Adrenergic alpha-Antagonists; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Humans; Mianserin; Middle Aged; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Time Factors | 2002 |
In the rat forced swimming test, NA-system mediated interactions may prevent the 5-HT properties of some subacute antidepressant treatments being expressed.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Biogenic Monoamines; Brain; Depression; Dopamine Agents; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Immobilization; Male; Mianserin; Mirtazapine; Motor Activity; Norepinephrine; Oxidopamine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Swimming | 2002 |
Prevention of the stress-induced increase in the concentration of neuroactive steroids in rat brain by long-term administration of mirtazapine but not of fluoxetine.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents, Second-Generation; Brain Chemistry; Cerebral Cortex; Chromatography, High Pressure Liquid; Desoxycorticosterone; Electroshock; Fluoxetine; Male; Mianserin; Mirtazapine; Pregnanolone; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Steroids; Stress, Psychological | 2002 |
In the rat forced swimming test, chronic but not subacute administration of dual 5-HT/NA antidepressant treatments may produce greater effects than selective drugs.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Clonidine; Cyclopropanes; Depression; Desipramine; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Male; Mianserin; Milnacipran; Mirtazapine; Motor Activity; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Selective Serotonin Reuptake Inhibitors; Swimming | 2002 |
Serotonin transporter modulation in blood lymphocytes from patients with major depression.
Topics: Adrenergic alpha-Antagonists; Adult; Antidepressive Agents, Second-Generation; Brain; Carrier Proteins; Depressive Disorder, Major; Down-Regulation; Female; Fluoxetine; Humans; Lymphocytes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mianserin; Mirtazapine; Nerve Tissue Proteins; Neuroimmunomodulation; Paroxetine; Radioligand Assay; Serotonin; Serotonin Plasma Membrane Transport Proteins; Treatment Outcome; Up-Regulation | 2002 |
[Psychotropic drugs used in a psychiatric hospital (pharmaco-epidemiologic aspects)].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Carbazoles; Chlorprothixene; Clopenthixol; Data Collection; Dopamine Antagonists; Female; Fluoxetine; Flupenthixol; Hospitals, Psychiatric; Humans; Male; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Monoamine Oxidase Inhibitors; Moscow; Nootropic Agents; Olanzapine; Pharmacoepidemiology; Phenothiazines; Psychotropic Drugs; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulpiride | 2003 |
Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Doxepin; Drug Overdose; Drug Prescriptions; Emergency Service, Hospital; Female; Fluoxetine; Humans; Imipramine; Information Services; Male; Mianserin; Mirtazapine; Paroxetine; Patient Admission; Patient Readmission; Poison Control Centers; Retrospective Studies; Risk Assessment; Scotland; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Trazodone; Venlafaxine Hydrochloride | 2004 |
Effect of mirtazapine versus fluoxetine on "sleep quality".
Topics: Antidepressive Agents, Tricyclic; Comorbidity; Depressive Disorder; Dose-Response Relationship, Drug; Fluoxetine; Humans; Mianserin; Mirtazapine; Research Design; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Initiation and Maintenance Disorders | 2004 |
Rapid screening of selective serotonin re-uptake inhibitors in urine samples using solid-phase microextraction gas chromatography-mass spectrometry.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Fluoxetine; Fluvoxamine; Gas Chromatography-Mass Spectrometry; Humans; Mianserin; Mirtazapine; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Solid Phase Microextraction; Venlafaxine Hydrochloride | 2005 |
Development of a solid phase extraction for 13 'new' generation antidepressants and their active metabolites for gas chromatographic-mass spectrometric analysis.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Desvenlafaxine Succinate; Fluoxetine; Gas Chromatography-Mass Spectrometry; Humans; Mianserin; Microchemistry; Mirtazapine; Piperazines; Reproducibility of Results; Sertraline | 2005 |
[A 74-year-old unconscious woman with myoclonia and seizures].
Topics: Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Citalopram; Female; Fluoxetine; Humans; Mianserin; Myoclonus; Olanzapine; Poisoning; Seizures; Selective Serotonin Reuptake Inhibitors; Unconsciousness | 2006 |
Successful treatment of anorexia with a combination of high-dose olanzapine, fluoxetine and mirtazapine.
Topics: Adult; Anorexia; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Fluoxetine; Humans; Mianserin; Mirtazapine; Olanzapine; Selective Serotonin Reuptake Inhibitors | 2006 |
An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials.
Topics: Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Fluoxetine; Humans; Kava; Mianserin; Mirtazapine; Paroxetine; Psychometrics; Sertraline; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Venlafaxine Hydrochloride | 2007 |
Geometric mean IELT and premature ejaculation: appropriate statistics to avoid overestimation of treatment efficacy.
Topics: Antidepressive Agents; Coitus; Data Interpretation, Statistical; Ejaculation; Fluoxetine; Fluvoxamine; Humans; Male; Mianserin; Mirtazapine; Models, Biological; Piperazines; Reaction Time; Research Design; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sertraline; Sexual Dysfunction, Physiological; Treatment Outcome; Triazoles | 2008 |
Antidepressant-associated mania: soon after switch from fluoxetine to mirtazapine in an elderly woman with mixed depressive features.
Topics: Adrenergic alpha-Antagonists; Aged; Bipolar Disorder; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Female; Fluoxetine; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors | 2009 |
Effect of antidepressants on body weight, ethology and tumor growth of human pancreatic carcinoma xenografts in nude mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Body Weight; Carcinoma; Cell Line, Tumor; Female; Fluoxetine; Male; Mianserin; Mice; Mice, Inbred BALB C; Mice, Nude; Mirtazapine; Neoplasm Transplantation; Pancreatic Neoplasms | 2008 |
Combining antidepressant medications: a good idea?
Topics: Antidepressive Agents; Bupropion; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Fluoxetine; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride | 2010 |
Loss of response after switching from brand name to generic formulations: three cases and a discussion of key clinical considerations when switching.
Topics: Drugs, Generic; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Secondary Prevention; Therapeutic Equivalency; Valproic Acid | 2010 |
An audit to compare discharge rates between antidepressant monotherapies prescribed for pure unipolar depression versus depression in the presence of other indications.
Topics: Adult; Antidepressive Agents; Citalopram; Community Mental Health Centers; Comorbidity; Cyclohexanols; Depressive Disorder; England; Fluoxetine; Guideline Adherence; Humans; Medical Audit; Mianserin; Mirtazapine; Patient Discharge; Practice Patterns, Physicians'; Sertraline; Suicide; Suicide Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Potentiation of omega-3 fatty acid antidepressant-like effects with low non-antidepressant doses of fluoxetine and mirtazapine.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Body Weight; Dose-Response Relationship, Drug; Drug Synergism; Fatty Acids, Omega-3; Fluoxetine; Male; Mianserin; Mirtazapine; Rats; Rats, Wistar; Swimming; Time Factors | 2010 |
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride | 2010 |
The effects of mirtazapine and fluoxetine on hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
Topics: Animals; Antidepressive Agents, Tricyclic; Disease Models, Animal; Fever; Fluoxetine; Male; Mianserin; Mirtazapine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Serotonin 5-HT2 Receptor Antagonists; Serotonin Agents | 2011 |
Antidepressants differentially modify the extinction of an aversive memory task in female rats.
Topics: Animals; Antidepressive Agents; Anxiety; Avoidance Learning; Extinction, Psychological; Female; Fluoxetine; Maze Learning; Memory; Mianserin; Mirtazapine; Nortriptyline; Psychomotor Performance; Rats; Rats, Wistar | 2012 |
Simultaneous determination of 25 common pharmaceuticals in whole blood using ultra-performance liquid chromatography-tandem mass spectrometry.
Topics: Analgesics; Antidepressive Agents; Antihypertensive Agents; Antipsychotic Agents; Chromatography, High Pressure Liquid; Clopenthixol; Fluoxetine; Histamine Antagonists; Humans; Limit of Detection; Linear Models; Methotrimeprazine; Methylphenidate; Mianserin; Mirtazapine; Pharmaceutical Preparations; Quality Control; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2012 |
Evaluation of the anti-ulcerogenic activity of the antidepressants duloxetine, amitriptyline, fluoxetine and mirtazapine in different models of experimental gastric ulcer in rats.
Topics: Amitriptyline; Animals; Anti-Ulcer Agents; Antidepressive Agents; Disease Models, Animal; Duloxetine Hydrochloride; Fluoxetine; Immersion; Indomethacin; Male; Mianserin; Mirtazapine; Rats; Rats, Sprague-Dawley; Reserpine; Restraint, Physical; Stomach Ulcer; Stress, Psychological; Thiophenes; Water | 2012 |
Influence of body mass index on the choice of therapy for depression and follow-up care.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Body Mass Index; Choice Behavior; Cohort Studies; Depression; Female; Fluoxetine; Follow-Up Studies; Humans; Logistic Models; Male; Mianserin; Middle Aged; Mirtazapine; Obesity; Paroxetine; Psychotherapy; Young Adult | 2013 |
Effect of co-treatment with fluoxetine or mirtazapine and risperidone on the active behaviors and plasma corticosterone concentration in rats subjected to the forced swim test.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Behavior, Animal; Corticosterone; Depression; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Exploratory Behavior; Fluoxetine; Male; Mianserin; Mirtazapine; Motor Activity; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Swimming | 2012 |
Human P-glycoprotein differentially affects antidepressant drug transport: relevance to blood-brain barrier permeability.
Topics: Amitriptyline; Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Capillary Permeability; Dogs; Duloxetine Hydrochloride; Fluoxetine; Humans; Imipramine; Madin Darby Canine Kidney Cells; Mianserin; Mirtazapine; Thiophenes; Transfection | 2013 |
Inhibitory effect of antidepressants on B16F10 melanoma tumor growth.
Topics: Animals; Antidepressive Agents; Cell Proliferation; Desipramine; Fluoxetine; Interleukin-10; Male; Melanoma, Experimental; Mianserin; Mice; Mice, Inbred C57BL; Mirtazapine; T-Lymphocytes; Tumor Cells, Cultured | 2013 |
Linking Clostridium difficile infection with depression.
Topics: Antidepressive Agents; Clostridioides difficile; Clostridium Infections; Depression; Fluoxetine; Humans; Mianserin; Mirtazapine; Risk Factors | 2013 |
Antidepressant action via the nitric oxide system: A pilot study in an acute depressive model induced by arginin.
Topics: Acute Disease; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Arginine; Cyclopropanes; Depression; Fluoxetine; Male; Mianserin; Milnacipran; Mirtazapine; Nitric Oxide; Nitric Oxide Synthase; Pilot Projects; Rats, Wistar; Selective Serotonin Reuptake Inhibitors | 2015 |
Atypical antidepressants extend lifespan of Caenorhabditis elegans by activation of a non-cell-autonomous stress response.
Topics: Aging; Animals; Antidepressive Agents, Second-Generation; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Catalase; Fluoxetine; Histamine H1 Antagonists; Life Expectancy; Longevity; Mianserin; Mirtazapine; Oxidative Stress; Peroxiredoxins; Reactive Oxygen Species; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Superoxide Dismutase; Synaptic Transmission | 2015 |
Effects of anti-depressant treatments on FADD and p-FADD protein in rat brain cortex: enhanced anti-apoptotic p-FADD/FADD ratio after chronic desipramine and fluoxetine administration.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Apoptosis; Autoreceptors; Blotting, Western; Brain; CASP8 and FADD-Like Apoptosis Regulating Protein; Cerebral Cortex; Clorgyline; Desipramine; Electroshock; Excitatory Amino Acid Antagonists; Fas-Associated Death Domain Protein; Fluoxetine; Idazoxan; Indans; Ketamine; Male; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Norepinephrine Plasma Membrane Transport Proteins; Phenelzine; Phosphoproteins; Phosphorylation; Rats; RNA-Binding Proteins; Thiazoles | 2016 |
Repeated co-treatment with antidepressants and risperidone increases BDNF mRNA and protein levels in rats.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Drug Interactions; Fluoxetine; Frontal Lobe; Gene Expression Regulation; Hippocampus; Mianserin; Mirtazapine; Rats; Rats, Wistar; Risperidone; RNA, Messenger; Serotonin Antagonists | 2017 |
Global transcriptomic analysis of zebrafish in response to embryonic exposure to three antidepressants, amitriptyline, fluoxetine and mianserin.
Topics: Amitriptyline; Animals; Antidepressive Agents; Fluoxetine; Gene Expression Profiling; Gene Expression Regulation, Developmental; High-Throughput Nucleotide Sequencing; Larva; Mianserin; RNA, Messenger; Sequence Analysis, RNA; Signal Transduction; Water Pollutants, Chemical; Zebrafish; Zebrafish Proteins | 2017 |
Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological Study.
Topics: Antidepressive Agents; Basal Ganglia Diseases; Bupropion; Case-Control Studies; Citalopram; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Pharmacoepidemiology; Sertraline; United States; Venlafaxine Hydrochloride | 2018 |
Antidepressants Differentially Regulate Intracellular Signaling from α1-Adrenergic Receptor Subtypes In Vitro.
Topics: Animals; Antidepressive Agents; Citalopram; Depression; Desipramine; Fluoxetine; Gene Expression Regulation; Humans; Imipramine; Mianserin; Mice; PC12 Cells; Rats; Reboxetine; Receptors, Adrenergic, alpha-1; Signal Transduction | 2021 |
Potential of sodium dodecyl sulfate micellar solutions as eluents in magnetic dispersive micro-solid phase extraction with polydopamine-coated magnetite nanoparticles. Application to antidepressant drugs.
Topics: Antidepressive Agents; Chromatography, High Pressure Liquid; Fluoxetine; Indoles; Magnetic Phenomena; Magnetite Nanoparticles; Mianserin; Micelles; Polymers; Sodium Dodecyl Sulfate; Solid Phase Extraction; Trimipramine | 2022 |
Treatment-Resistant Depression (TRD): Is the Opioid System Involved?
Topics: Analgesics, Opioid; Animals; Antidepressive Agents; Depression; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Mianserin; Mice; Mirtazapine; Moclobemide; Naloxone; Reboxetine; Trazodone; Venlafaxine Hydrochloride | 2023 |